ID

13159

Descripción

Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML); ODM derived from: https://clinicaltrials.gov/show/NCT00074750

Link

https://clinicaltrials.gov/show/NCT00074750

Palabras clave

Versiones (1)
  1. 20/1/16 20/1/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

20 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Myelogenous Leukemia NCT00074750

Inglés

Eligibility Acute Myelogenous Leukemia NCT00074750

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with refractory or relapsed aml ( marrow blasts > 20% ), must have failed induction therapy or have relapsed after cr duration < 6 months following induction therapy, untreated or refractory to salvage chemotherapy. relapsed aml patients with cr duration > 6 months or previously untreated patients refusing chemotherapy and not considered for treatments of higher priority are also eligible.
Descripción

refractory or relapsed aml

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023467
patients with chronic myelomonocytic leukemia (cmml) who failed at least one course of chemo- or biological therapy( including trial of erythropoietin), or patients with relapsed cmml. previously untreated cmml patients with hb < or = 12 g / dl, not eligible for protocols of higher priority or not wishing to receive chemotherapy.
Descripción

chronic myelomonocytic leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023480
patients must have an ecog performance status of < 2.
Descripción

ecog performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
patients must have wbc count < 10,000/ml prior to initiating the treatment. the wbc count must be stabilized below this level for at least three days by leukopheresis or hydroxyurea. hydroxyurea must be discontinued one day prior to initiation of dt388gmcsf treatment.
Descripción

wbc count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
patients must have creatinine < 1.6 times uln: bilirubin <1.6 times uln; sgpt < 2.6 x uln; albumin > 3 gm/dl; adequate cardiac function (ef >44%), oxygen saturation > 92% without exogenous oxygen administered.
Descripción

organ parameters

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201838
UMLS CUI [5]
C0232174
UMLS CUI [6]
C0523807
patients must be willing to be treated at m d anderson cancer center.
Descripción

patients must be willing to be treated at m d anderson cancer center.

Tipo de datos

boolean

women of childbearing potential and men must agree to practice contraception using approved methods.
Descripción

contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
no chemotherapy except hydroxyurea 2 weeks prior to entering the study and recovered from previous toxicity.
Descripción

chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
patients must be > 17 years old.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with serious concurrent medical problems. patients with proven bacterial infections are not eligible until the resolution of the infection (patient afebrile who completed antibacterial therapy, not on steroids). patients with active fungal infections are eligible only if evidence of response to antifungal medications is documented and fever does not exceed 38c for at least 2 days.
Descripción

infections

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
inability to give informed consent because of psychiatric problems or other serious medical problems.
Descripción

inability to give informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
pregnant or nursing women.
Descripción

pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients with documented cns leukemia or leukemia with cns symptoms.
Descripción

cns leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1332884
patients who have had a myocardial infarction within the past six months.
Descripción

myocardial infarction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
patients with severe penicillin allergy (anaphylaxis).
Descripción

penicillin allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0030840
not fully recovered from toxic effects of prior chemotherapy or radiation therapy.
Descripción

toxic effects of chemotherapy or radiation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
patients who are on corticosteroid treatment for any medical condition.
Descripción

corticosteroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001617
Volver a la parte superior de la página

Similar models

Eligibility Acute Myelogenous Leukemia NCT00074750

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
refractory or relapsed aml
Item
patients with refractory or relapsed aml ( marrow blasts > 20% ), must have failed induction therapy or have relapsed after cr duration < 6 months following induction therapy, untreated or refractory to salvage chemotherapy. relapsed aml patients with cr duration > 6 months or previously untreated patients refusing chemotherapy and not considered for treatments of higher priority are also eligible.
boolean
C0023467 (UMLS CUI [1])
chronic myelomonocytic leukemia
Item
patients with chronic myelomonocytic leukemia (cmml) who failed at least one course of chemo- or biological therapy( including trial of erythropoietin), or patients with relapsed cmml. previously untreated cmml patients with hb < or = 12 g / dl, not eligible for protocols of higher priority or not wishing to receive chemotherapy.
boolean
C0023480 (UMLS CUI [1])
ecog performance status
Item
patients must have an ecog performance status of < 2.
boolean
C1520224 (UMLS CUI [1])
wbc count
Item
patients must have wbc count < 10,000/ml prior to initiating the treatment. the wbc count must be stabilized below this level for at least three days by leukopheresis or hydroxyurea. hydroxyurea must be discontinued one day prior to initiation of dt388gmcsf treatment.
boolean
C0023508 (UMLS CUI [1])
organ parameters
Item
patients must have creatinine < 1.6 times uln: bilirubin <1.6 times uln; sgpt < 2.6 x uln; albumin > 3 gm/dl; adequate cardiac function (ef >44%), oxygen saturation > 92% without exogenous oxygen administered.
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201838 (UMLS CUI [4])
C0232174 (UMLS CUI [5])
C0523807 (UMLS CUI [6])
patients must be willing to be treated at m d anderson cancer center.
Item
patients must be willing to be treated at m d anderson cancer center.
boolean
contraception
Item
women of childbearing potential and men must agree to practice contraception using approved methods.
boolean
C0700589 (UMLS CUI [1])
chemotherapy
Item
no chemotherapy except hydroxyurea 2 weeks prior to entering the study and recovered from previous toxicity.
boolean
C0392920 (UMLS CUI [1])
age
Item
patients must be > 17 years old.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
infections
Item
patients with serious concurrent medical problems. patients with proven bacterial infections are not eligible until the resolution of the infection (patient afebrile who completed antibacterial therapy, not on steroids). patients with active fungal infections are eligible only if evidence of response to antifungal medications is documented and fever does not exceed 38c for at least 2 days.
boolean
C0009450 (UMLS CUI [1])
inability to give informed consent
Item
inability to give informed consent because of psychiatric problems or other serious medical problems.
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
pregnancy or lactation
Item
pregnant or nursing women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
cns leukemia
Item
patients with documented cns leukemia or leukemia with cns symptoms.
boolean
C1332884 (UMLS CUI [1])
myocardial infarction
Item
patients who have had a myocardial infarction within the past six months.
boolean
C0027051 (UMLS CUI [1])
penicillin allergy
Item
patients with severe penicillin allergy (anaphylaxis).
boolean
C0020517 (UMLS CUI [1,1])
C0030840 (UMLS CUI [1,2])
toxic effects of chemotherapy or radiation
Item
not fully recovered from toxic effects of prior chemotherapy or radiation therapy.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
corticosteroids
Item
patients who are on corticosteroid treatment for any medical condition.
boolean
C0001617 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial